• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P388白血病5-氟尿嘧啶耐药亚系的生化特性

Biochemical characteristics of a 5-fluorouracil-resistant subline of P388 leukemia.

作者信息

Tezuka M, Sugiyama H, Tamemasa O, Inaba M

出版信息

Gan. 1982 Feb;73(1):70-6.

PMID:7117749
Abstract

A 5-fluorouracil (5-FU)-resistant cell line of P388 mouse leukemia was established by intraperitoneal treatment with the drug. The activities of enzymes responsible for the formation of 5-fluoro-2'-deoxyuridine 5'-monophosphate and 5-fluorouridine 5'-monophosphate from 5-FU, the quantities of 5-FU metabolites, and the permeability to 5-FU were determined in both the 5-FU-sensitive and the resistant cell lines. It was found that the activities of uridine kinase and uracil phosphoribosyltransferase, the initial uptake of 5-FU, and the intracellular levels of 5-FU-nucleotides were all decreased in the resistant cells. However, the initial uptake of 5-FU into cells preincubated with KCN was the same in the sensitive and the resistant cells. These results support the view that the ineffectiveness of 5-FU against the resistant cell line of P388 leukemia can be attributed to decreases in the activities of enzymes responsible for the formation of 5-FU-nucleotides and probably also decreased transport of 5-FU in the resistant cells.

摘要

通过腹腔注射5-氟尿嘧啶(5-FU)建立了P388小鼠白血病的5-FU耐药细胞系。测定了5-FU敏感和耐药细胞系中负责从5-FU形成5-氟-2'-脱氧尿苷5'-单磷酸和5-氟尿苷5'-单磷酸的酶活性、5-FU代谢产物的量以及对5-FU的通透性。结果发现,耐药细胞中尿苷激酶和尿嘧啶磷酸核糖基转移酶的活性、5-FU的初始摄取以及5-FU核苷酸的细胞内水平均降低。然而,用KCN预孵育的细胞对5-FU的初始摄取在敏感细胞和耐药细胞中是相同的。这些结果支持这样一种观点,即5-FU对P388白血病耐药细胞系无效可归因于负责5-FU核苷酸形成的酶活性降低,并且可能还归因于耐药细胞中5-FU的转运减少。

相似文献

1
Biochemical characteristics of a 5-fluorouracil-resistant subline of P388 leukemia.P388白血病5-氟尿嘧啶耐药亚系的生化特性
Gan. 1982 Feb;73(1):70-6.
2
Biochemical characterization of fluoropyrimidine-resistant murine leukemic cell lines.氟嘧啶耐药小鼠白血病细胞系的生化特性
Cancer Res. 1982 Mar;42(3):965-73.
3
[Activities of enzymes converting 5-fluorouracil to 5-fluorouridine-5' monophosphate and 5-fluorodeoxyuridine-5' monophosphate in subcultured cell lines and solid tumor tissues].[传代细胞系和实体瘤组织中5-氟尿嘧啶转化为5-氟尿苷-5'-单磷酸和5-氟脱氧尿苷-5'-单磷酸的酶活性]
Nihon Gan Chiryo Gakkai Shi. 1990 May 20;25(5):990-6.
4
Role of uridine phosphorylase in the anabolism of 5-fluorouracil.
Biochem Pharmacol. 1985 Oct 1;34(19):3585-9. doi: 10.1016/0006-2952(85)90737-3.
5
Mechanism for resistance to 5-fluorouracil in P388 leukemia cells.
J Pharmacobiodyn. 1991 Oct;14(10):577-81. doi: 10.1248/bpb1978.14.577.
6
Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes.人、小鼠和大鼠细胞对5-氟尿嘧啶和5'-脱氧-5-氟尿苷的敏感性与药物代谢酶的关系。
Cancer Res. 1986 Jan;46(1):20-8.
7
Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine.齐多夫定对人结肠肿瘤细胞系5-氟尿嘧啶耐药性的调节作用
Oncol Res. 1996;8(5):189-96.
8
[Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts].α-干扰素与5-氟尿嘧啶联合应用对人肝癌异种移植瘤5-氟尿嘧啶代谢的影响
Gan To Kagaku Ryoho. 2004 Oct;31(10):1511-5.
9
Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.马铃薯(Solanum tuberosum L.)块茎圆盘嘧啶生物合成、补救和降解的概况。
Planta. 2002 Sep;215(5):821-8. doi: 10.1007/s00425-002-0806-5. Epub 2002 Jun 21.
10
An update on the biochemistry of 5-fluorouracil.
Cancer Treat Rev. 1981 Sep;8(3):157-67. doi: 10.1016/s0305-7372(81)80014-x.

引用本文的文献

1
Lack of in vivo cross-resistance with 4'-thio-ara-C against drug-resistant murine P388 and L1210 leukemias.体内缺乏 4'-硫代阿糖胞苷对耐药鼠 P388 和 L1210 白血病的交叉耐药性。
Cancer Chemother Pharmacol. 2011 Aug;68(2):399-403. doi: 10.1007/s00280-010-1498-3. Epub 2010 Nov 11.